The 'cephalosporin era' of triazole therapy: Isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections
© 2015 Informa UK, Ltd. Introduction: Invasive fungal infections remain frequent life-threatening complications in immunocompromised patients. Each of the currently available antifungals has limitations in terms of pharmacokinetic and pharmacodynamic profile, spectrum of efficacy, and tolerability....
Saved in:
Main Authors: | Maria N. Chitasombat, Dimitrios P. Kontoyiannis |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36859 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Treatment of mucormycosis in transplant patients: Role of surgery and of old and new antifungal agents
by: Maria N. Chitasombat, et al.
Published: (2018) -
Empirical cephalosporin treatment of melioidosis
by: Wipada Chaowagul, et al.
Published: (2018) -
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections
by: Issam I. Raad, et al.
Published: (2018) -
Immunomodulation as therapy for fungal infection: Are we closer?
by: Sam, Q.H., et al.
Published: (2020) -
Third generation cephalosporins
by: อโนชา อุทัยพัฒน์
Published: (2020)